PPM-18 is a naphthoquinone compound that inhibits NF-κB activation in vitro and in vivo (IC50 = 5 μM). Through this action, it inhibits the expression of inducible nitric oxide synthase (iNOS) in macrophages treated with lipopolysaccharide and suppresses inflammation and sepsis.
